CSL Behring AG

CSL Behring AG is a biotechnology company. The Company focuses on developing a wide range of recombinant and plasma-derived products for treating bleeding disorders, immune deficiencies, and chronic inflammatory demyelinating polyneuropathy, as well as hereditary angioedema and alpha 1 antitrypsin deficiency. CSL Behring serves medical industry globally.